Intelligence / Healthtech / De Novo Grants / Cm Technologies, Inc.
Approvalsnovel device granted (FDA De Novo)20 Aug 2026
Cm Technologies, Inc.
20 Aug 2026: Novel device granted (FDA De Novo) · Qoramatic Automated Stool Management. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 20 Aug 2026
- Device
- Qoramatic Automated Stool Management
- Specialty
- Gastroenterology, Urology
- Product Code
- SJB
- Country
- United States
- Location
- Carrollton, TX
- Submitted
- 2025-09-15
- Reference
- DEN250043
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Cm Technologies, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Cm Technologies, Inc. in our registers.
More in Gastroenterology, Urology
De Novo Grants
30 AprCathbuddy, Inc.novel device granted (FDA De Novo) · Aurie SystemApprovals15 JanBridge TO Life, Ltd.novel device granted (FDA De Novo) · VitaSmart Hypothermic Oxygenated Perfusion SystemApprovals17 OctNeurovalens Limitednovel device granted (FDA De Novo) · Modius LeanApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.